Alpha-1 Antitrypsin Deficiency in a French General Hospital: Fortuitous Detection Rather Than Efficient Screening

Total Page:16

File Type:pdf, Size:1020Kb

Alpha-1 Antitrypsin Deficiency in a French General Hospital: Fortuitous Detection Rather Than Efficient Screening Alpha-1 antitrypsin deficiency in a French General Hospital: fortuitous detection rather than efficient screening. Hakim Kherouf, Geoffroy de Faverges, Pierre J.J. Dumont, Evelyne Bourgerette, Tu N’Guyen, Olivier Moquet To cite this version: Hakim Kherouf, Geoffroy de Faverges, Pierre J.J. Dumont, Evelyne Bourgerette, Tu N’Guyen, et al.. Alpha-1 antitrypsin deficiency in a French General Hospital: fortuitous detection rather than efficient screening.. Advances in Respiratory Medicine, Via Medica, 2018, 86 (4), pp.179-182. 10.5603/ARM.a2018.0027. hal-01382807v3 HAL Id: hal-01382807 https://hal.archives-ouvertes.fr/hal-01382807v3 Submitted on 11 Dec 2018 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. ORIGINAL RESEARCH Hakim Kherouf1, Geoffroy De Faverges2, Pierre Dumont1, Evelyne Bourgerette1, Tu Nguyen3, Olivier Moquet1 1Laboratoire de Biologie Medicale, Centre Hospitalier de l’Agglomération de Nevers, France 2Service de Pneumologie, Centre Hospitalier de l’Agglomération de Nevers, France 3Département de l’Information Medicale, Centre Hospitalier de l’Agglomération de Nevers, France Alpha-1 antitrypsin deficiency in a French General Hospital: fortuitous detection rather than efficient screening The authors declare no financial disclosure Abstract Introduction: We studied the characteristics of the screening procedure for alpha-1 antitrypsin at Nevers Hospital (France), together with the performance of serum protein gel electrophoresis for the fortuitous detection of patients with deficiency. Material and methods: We carried out a retrospective study of requests for alpha-1 antitrypsin determination referred to the laboratory during 3 years. We compared these requests with the numbers of patients seen at the hospital and requiring screening according to international recommendations. In parallel, we reviewed all the serum protein gel electrophoresis results obtained during the same period. Results: The laboratory received 102 direct requests for alpha-1 antitrypsin determination, whereas more than 1397 patients presented an indication for screening. No case of alpha-1 antitrypsin deficiency was detected among the 102 patients screened. In parallel, 5551 serum protein gel electrophoresis analyses were carried out at the laboratory. A decrease in the size of the alpha-1 globulin fraction was detected in 68 patients. Seventeen of these patients underwent alpha-1 antitrypsin determinations and 14 were found to have alpha-1 antitrypsin deficiency. Conclusion: Alpha-1 antitrypsin deficiency was more frequently detected fortuitously, by electrophoresis, than through efficient screening. The exploration of alpha-1 globulin deficiencies by serum protein gel electrophoresis thus appears to be still a particu- larly efficient approach to the detection of alpha-1 antitrypsin deficiency and should be carried out systematically. Furthermore, the testing of all patients with an indication for screening according to international recommendations should be encouraged. Key words: alpha-1 antitrypsin deficiency, serum protein electrophoresis, agar gel electrophoresis, PI phenotype, screening Adv Respir Med. 2018; 86: 179–182 Introduction cies of alpha-1 antitrypsin (AAT), the principal plasma protease inhibitor, based on the absence of Carl-Bertil Laurell, a biochemist at the Uni- a serum alpha-1 fraction on SPE. In collaboration versity of Malmö, was one of the pioneers of the with Sten Erikson, he subsequently demonstrated development of serum protein electrophoresis the relationship between AAT deficiency and the (SPE) as a diagnostic tool in medicine. In 1961, development of emphysema [1]. he introduced the use of agarose gels, in place Today, the biological diagnosis of AAT defi- of paper, as a support for the migration and se- ciency is based on sensitive and specific quanti- paration of proteins, a “standard” technique still fications of plasma AAT by immunoturbidimetry widely used in medical laboratories. In 1963, he or nephelometry, which is then followed by identified the first patients with severe deficien- isoelectric focusing to phenotype the most com- Address for correspondence: Olivier Moquet, Laboratoire de Biologie Médicale, Centre Hospitalier de l’Agglomération de Nevers 1, Boulevard de l’Hôpital 58 000 Nevers, France, Tel. +33 (0)3 86 93 73 67, Fax : +33 (0)3 86 93 73 61, e-mail: [email protected] DOI: 10.5603/ARM.a2018.0027 Received: 21.06.2018 Copyright © 2018 PTChP ISSN 2451–4934 www.journals.viamedica.pl 179 Advances in Respiratory Medicine 2018, vol. 86, no. 4, pages 179–182 mon variants, or genotyping [2]. In France, these This study has been declared to the CNIL, the examinations are carried out by a few specialized French Commission for Data Protection & Civil laboratories, but testing is accessible nationwide, Liberties (No. 1860860). via subcontracting through a network of hospital and private medical laboratories. Nevertheless, Results AAT deficiency remains underdiagnosed in Fran- ce and worldwide, despite the existence of inter- The laboratory received 119 requests, inclu- national recommendations for screening [2]. It is ding 102 direct requests for AAT determination, estimated, for example, that only 5 to 10% of the during the study period. Overall, 28 of the tests 7,500 to 10,000 patients with the PiZ phenotype, were performed for the exploration of liver di- the most severe form of this deficiency, have been sorders, 70 for respiratory disorders (32 for em- identified in France [3, 4], and that this condition physema, 28 for chronic obstructive pulmonary is diagnosed on average 10 years after the appe- disease (COPD), 5 for asthma, 5 for sleep apnea, arance of the first symptoms [5]. In Poland, the and 2 for pneumothorax), 1 in the context of number of patients with the PiZ phenotype is vasculitis, and 3 for unknown indications (not estimated to be between 4,189 and 7,000 [6]. recorded). No cases of AAT deficiency were de- Serum protein electrophoresis remains as re- tected in the 102 directly requested AAT deter- levant as ever and is still widely prescribed for the minations. Over the same period, 1,397 patients exploration of various diseases (hematological, li- admitted to the hospital had an indication for ver, renal and inflammatory diseases, for example). screening: 1,180 had COPD, 147 had pulmonary The widespread use of this technique may emphysema, 38 had partially irreversible asth- still allow the fortuitous discovery of patients ma, 27 had bronchiectasis of unknown etiology, with AAT deficiency. We studied the characteri- four had anti-PR3 antibody-positive vasculitis stics of screening for AAT deficiency at Nevers and one had panniculitis. It was not possible to Hospital (NH), and the performance of SPE for determine the number of patients with unexpla- the incidental discovery of AAT deficiency in ined liver disease or bronchial obstruction. One patients. patient had already been diagnosed with AAT deficiency (PiMZ). Material and methods In parallel, 5,551 SPE tests were performed at the laboratory, on serum samples from 4,406 We retrospectively reviewed all requests for patients. The alpha-1 globulin fraction was ab- AAT determination (± typing) received by the normally small in 68 patients. In response to the laboratory during 3 years (May 2012 to May 2015) comment added to the results concerning the pos- (subcontracted tests), noting the reasons for the sibility of a deficiency, 17 subjects underwent AAT prescription of the tests and their results. We assays (and typing by isoelectric focusing in cases compared the number of tests performed with the of confirmed deficiency; Fig. 1). AAT deficiency number of patients hospitalized at the NH eligible (AAT concentration < 0.93 g/L, the reference value for screening in accordance with international of the subcontractor laboratory) was confirmed in recommendations or already diagnosed as having 14 of the 17 patients (82%; Fig. 1). The deficiency AAT deficiency, by performing statistical queries phenotypes were as follows: two PiZZ, four PiSZ, in the PMSI of the hospital (PMSI, programme de one PiSS, five PiMZ, and two PiMS. The results médicalisation des systèmes d’information; the for the alpha-1 globulin fraction and AAT deter- hospital medico-administrative database). mination for these 17 patients are summarized in In parallel, we reviewed all SPE tests perfor- Figure 1, and the characteristics of the 14 subjects med in the laboratory over the same period. Gel with AAT deficiencies are presented in Table 1. electrophoresis was performed on a Hydrasys -Hyrys device (Sebia). For all tests in which the Discussion alpha-1 globulin fraction was smaller than the value considered normal according to laboratory Screening characteristics standards (< 1 g/L, rounded to the nearest decimal The lack of detection of AAT deficiency in place), in the absence of an obvious cause (he- any of the 102 patients directly referred for testing patocellular insufficiency, severe undernutrition, is not entirely surprising. Despite the widespread protein leakage), a comment
Recommended publications
  • Types of Acute Phase Reactants and Their Importance in Vaccination (Review)
    BIOMEDICAL REPORTS 12: 143-152, 2020 Types of acute phase reactants and their importance in vaccination (Review) RAFAAT H. KHALIL1 and NABIL AL-HUMADI2 1Department of Biology, College of Science and Technology, Florida Agricultural and Mechanical University, Tallahassee, FL 32307; 2Office of Vaccines, Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, MD 20993, USA Received May 10, 2019; Accepted November 25, 2019 DOI: 10.3892/br.2020.1276 Abstract. Vaccines are considered to be one of the most human and veterinary medicine. Proteins which are expressed cost-effective life-saving interventions in human history. in the acute phase are potential biomarkers for the diagnosis The body's inflammatory response to vaccines has both of inflammatory disease, for example, acute phase proteins desired effects (immune response), undesired effects [(acute (APPs) are indicators of successful organ transplantation phase reactions (APRs)] and trade‑offs. Trade‑offs are and can be used to predict the ameliorative effect of cancer more potent immune responses which may be potentially therapy (1,2). APPs are primarily synthesized in hepatocytes. difficult to separate from potent acute phase reactions. The acute phase response is a spontaneous reaction triggered Thus, studying acute phase proteins (APPs) during vaccina- by disrupted homeostasis resulting from environmental distur- tion may aid our understanding of APRs and homeostatic bances (3). Acute phase reactions (APRs) usually stabilize changes which can result from inflammatory responses. quickly, after recovering from a disruption to homeostasis Depending on the severity of the response in humans, these within a few days to weeks; however, APPs expression levels reactions can be classified as major, moderate or minor.
    [Show full text]
  • Influence of Infection and Inflammation on Biomarkers of Nutritional Status
    A2.4 INFLUENCE OF INFECTION AND INFLAMMATION ON BIOMARKERS OF NUTRITIONAL STATUS A2.4 Influence of infection and inflammation on biomarkers of nutritional status with an emphasis on vitamin A and iron David I. Thurnham1 and George P. McCabe2 1 Northern Ireland Centre for Food and Health, University of Ulster, Coleraine, United Kingdom of Great Britain and Northern Ireland 2 Statistics Department, Purdue University, West Lafayette, Indiana, United States of America Corresponding author: David I. Thurnham; [email protected] Suggested citation: Thurnham DI, McCabe GP. Influence of infection and inflammation on biomarkers of nutritional status with an emphasis on vitamin A and iron. In: World Health Organization. Report: Priorities in the assessment of vitamin A and iron status in populations, Panama City, Panama, 15–17 September 2010. Geneva, World Health Organization, 2012. Abstract n Many plasma nutrients are influenced by infection or tissue damage. These effects may be passive and the result of changes in blood volume and capillary permeability. They may also be the direct effect of metabolic alterations that depress or increase the concentration of a nutrient or metabolite in the plasma. Where the nutrient or metabolite is a nutritional biomarker as in the case of plasma retinol, a depression in retinol concentrations will result in an overestimate of vitamin A deficiency. In contrast, where the biomarker is increased due to infection as in the case of plasma ferritin concentrations, inflammation will result in an underestimate of iron deficiency. Infection and tissue damage can be recognized by their clinical effects on the body but, unfortunately, subclinical infection or inflammation can only be recognized by measur- ing inflammation biomarkers in the blood.
    [Show full text]
  • Role of Myeloid-Derived Suppressor Cells in Tumor-Associated Pregnancy
    MASTER THESIS IN MEDECINE No 747 Role of Myeloid-Derived Suppressor Cells in tumor-associated pregnancy Student Sabine Waeber Tutor Prof. Ivan Stamenkovic Institute of Pathology, CHUV Supervisor Marie-Aude Le Bitoux, Postdoctoral Fellow Expert Prof. Michel Aguet Institute of Pathology, EPFL-ISREC Lausanne, December 2012 1 ABSTRACT 3 INTRODUCTION 4 1. Tumor-host interactions ......................................................................................................................... 4 2. Metastasis during pregnancy .................................................................................................................. 4 3. Immunity & pregnancy ........................................................................................................................... 5 4. MDSC and their potential role in pregnancy .......................................................................................... 5 SPECIFIC AIMS OF THE STUDY 7 RESULTS & DISCUSSION 8 1. Gene expression profiles of MDSC extracted from pregnant mice display features that may augment permissiveness for tumor progression ............................................................................................................. 8 1.1. Results 8 1.1.1. Enrichment of MDSC 8 1.1.2. Hybridization on Affymetrix microarrays 9 1.1.3. Validation of microarray results by qReal-Time RT-PCR 11 1.1.4. Comparison of MDSC genes expressed in pregnant and tumor-bearing mice 12 1.2. Discussion 13 2. MDSC functions during human pregnancy .........................................................................................
    [Show full text]
  • Normal Fibronectin Levels As a Function of Age in the Pediatric Population
    Pediatr. Res. 17: 482-485 (1983) Normal Fibronectin Levels as a Function of Age in the Pediatric Population MICHAEL H. MCCAFFERTY,'~"MARTHA LEPOW, THOMAS M. SABA,'21' ESHIN CHO, HILAIRE MEUWISSEN, JOHN WHITE, AND SHARON F. ZUCKERBROD Departments of Physiology and Pediatrics, Albany Medical College of Union University, Albany, New York, USA Summary pediatric population with age has not been reported. This may be important in terms of appropriate interpretation of prevailing Fibronectin is an important non-immune opsonic protein influ- levels in children with various disease states, because normal encing phagocytic clearance of blood-borne nonbacterial particu- concentrations in children may be different from normal levels in lates which may arise in association with septic shock, tissue adults. This study was designed to measure fibronectin levels in a injury, and intravascular coagulation. In the present study, serum large group (n = 114) of normal children in order to define its fibronectin was measured by both electroimmunoassay as well as normal concentration as a function of age. rapid immunoturbidimetric assay in healthy children (n = 114) ranging in age from 1 month to 15 years in order to delineate the temporal alterations in fibronectin with age. Normal adult serum MATERIALS AND METHODS fibronectin concentrations are typically 220 pg/ml + 20 pg/ml. Serum concentration is 3540% lower than normal plasma con- Healthy children (n = 114) ranging in age from 1 month to 15 centration due to the binding of fibronectin to fibrin during clot years were seen as outpatients or as inpatients for minor surgical formation. Children between 1-12 months of age had significantly procedures.
    [Show full text]
  • LEUKOCYTE SURFACE ORIGIN of HUMAN At-ACID GLYCOPROTEIN (OROSOMUCOID)*
    LEUKOCYTE SURFACE ORIGIN OF HUMAN at-ACID GLYCOPROTEIN (OROSOMUCOID)* BY CARL G. GAHMBERG AND LEIF C. ANDERSSON (From the Department of Bacteriology and Immunology, and the Transplantation Laboratory, Department of Surgery IV, University of Helsinki, Helsinki 29, Finland) Human al-acid glycoprotein (orosomucoid) (o~I-AG)1 constitutes the main component of the seromucoid fraction of human plasma. It belongs to the acute phase proteins, which increase under conditions such as inflammation, pregnancy, and cancer (1, 2). al-AG has previously been found to be synthesized in liver (3), and after removal of terminal sialic acids, it is cleared from the circulation by binding to a receptor protein on liver cell plasma membranes (4). The structure of al-AG is well known. It is composed of a single polypeptide chain and contains 245% carbohydrate including a large amount of sialic acid. The carbohydrate is located in the first half of the peptide chain linked to asparagine residues (5, 6). The function of al-AG is unclear. However, Schmid et al. (5) and Ikenaka et al. (7) and reported that the amino acid sequence of the protein shows a significant homology with human IgG. This finding and the striking increase in inflammatory and lymphopro- liferative disorders made us consider the possibility that leukocytes could be directly involved in the synthesis and release of a~-AG. We report here the presence of a membrane form of al-AG, with an apparent tool wt of 52,000, on normal human lymphocytes, granulocytes, and monocytes. By the use of internal labeling with [3H]leucine in vitro, we demonstrate that the membrane protein is synthesized by lymphocytes.
    [Show full text]
  • Downloaded from Bioscientifica.Com at 09/25/2021 07:25:24AM Via Free Access 812 M Andreassen and Others EUROPEAN JOURNAL of ENDOCRINOLOGY (2012) 166
    European Journal of Endocrinology (2012) 166 811–819 ISSN 0804-4643 CLINICAL STUDY GH activity and markers of inflammation: a crossover study in healthy volunteers treated with GH and a GH receptor antagonist Mikkel Andreassen1, Jan Frystyk2,3, Jens Faber1,4 and Lars Østergaard Kristensen1 1Endocrine Unit, Laboratory of Endocrinology 54o4, Department of Internal Medicine O, Herlev Hospital, University of Copenhagen, Herlev Ringvej 75, DK-2730 Herlev, Denmark, 2Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark and 3Medical Research Laboratories, Faculty of Health Sciences, Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark and 4Faculty of Health Science, Copenhagen University, Copenhagen, Denmark (Correspondence should be addressed to M Andreassen; Email: [email protected]) Abstract Introduction: The GH/IGF1 axis may modulate inflammatory processes. However, the relationship seems complicated as both pro- and anti-inflammatory effects have been demonstrated. Methods/design: Twelve healthy volunteers (mean age 36, range 27–49 years) were treated in random order with increasing doses of GH for 3 weeks (first week 0.01 mg/kg per day, second week 0.02 mg/kg per day, and third week 0.03 mg/kg per day) or a GH receptor antagonist (pegvisomant; first week 10 mg/day and last two weeks 15 mg/day), separated by 8 weeks of washout. Circulating levels of the pro-inflammatory cytokines tumor necrosis factor a (TNFa (TNFA)), interleukin 6 (IL6), and IL1b (IL1B) and the acute phase proteins (APPs) C-reactive protein (CRP), haptoglobin, orosomucoid, YKL40 (CHI3L1), and fibrinogen were measured. Results: During GH treatment, IGF1 (median 131 (Inter-quartile range (IQR) 112–166) vs 390 (322– 524) mg/l, PZ0.002) increased together with TNFa (0.87 (0.74–1.48) vs 1.27 (0.80–1.69) ng/l, PZ0.003), IL6 (1.00 (0.83–1.55) vs 1.35 (0.80–4.28) ng/l, PZ0.045), and fibrinogen (9.2 (8.8–9.6) vs 11.1 (9.4–12.4) mM, PZ0.002).
    [Show full text]
  • Sex Hormone-Binding Globulin (SHBG) As an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
    International Journal of Molecular Sciences Review Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome Xianqin Qu 1,* and Richard Donnelly 2 1 School of Life Sciences, University of Technology Sydney, Ultimo, NSW 2007, Australia 2 School of Medicine, University of Nottingham, Derby DE22 3DT, UK; [email protected] * Correspondence: [email protected]; Tel.: +61-2-95147852 Received: 1 October 2020; Accepted: 28 October 2020; Published: 1 November 2020 Abstract: Human sex hormone-binding globulin (SHBG) is a glycoprotein produced by the liver that binds sex steroids with high affinity and specificity. Clinical observations and reports in the literature have suggested a negative correlation between circulating SHBG levels and markers of non-alcoholic fatty liver disease (NAFLD) and insulin resistance. Decreased SHBG levels increase the bioavailability of androgens, which in turn leads to progression of ovarian pathology, anovulation and the phenotypic characteristics of polycystic ovarian syndrome (PCOS). This review will use a case report to illustrate the inter-relationships between SHBG, NAFLD and PCOS. In particular, we will review the evidence that low hepatic SHBG production may be a key step in the pathogenesis of PCOS. Furthermore, there is emerging evidence that serum SHBG levels may be useful as a diagnostic biomarker and therapeutic target for managing women with PCOS. Keywords: adolescents; hepatic lipogenesis; human sex hormone-binding globulin; insulin resistance; non-alcoholic fatty liver disease; polycystic ovary syndrome 1. Introduction Polycystic ovary syndrome (PCOS) is a complex, common reproductive and endocrine disorder affecting up to 10% of reproductive-aged women [1].
    [Show full text]
  • Conalbumin More Resistant to Proteolysis and Ther- the Use Of
    IRON AND PROTEIN KINETICS STUDIED BY MEANS OF DOUBLY LABELED HUMAN CRYSTALLINE TRANSFERRIN * BY JAY H. KATZ (From the Radioisotope and Medical Services of the Boston Veterans Administration Hospital, and the Dept. of Medicine, Boston University School of Medicine, Boston, Mass.) (Submitted for publication June 16, 1961; accepted August 10, 1961) Although proteins isotopically labeled with io- demonstrated that not only is the iron complex of dine have been used in tracer studies for some conalbumin more resistant to proteolysis and ther- years, interest has been mainly focused on their mal denaturation than the metal-free protein, but distribution and degradation in the body. While it that it is possible to maintain the iron-binding ca- is often possible to produce iodoproteins whose pacity of the former after extensive iodination. physical and chemical properties are not grossly Since both iron and transferrin levels are af- altered, the possible effects of iodination on the fected in a variety of disease states, a technique functional properties of such substances in a in which both can be followed simultaneously in physiologic setting have been less thoroughly in- vivo should prove valuable. Elmlinger and co- vestigated. That it is possible to trace label pro- workers (18) have reported in abstract form on teins without significantly reducing their biologi- the use of doubly labeled "iron-binding globulin" cal activities has been demonstrated in the case of in human subjects, but few details were given as insulin (2) and certain anterior pituitary hor- to the methods of preparation and the distribution mones (3, 4). of the two labels.
    [Show full text]
  • The Acute-Phase Protein Orosomucoid Regulates Food Intake and Energy Homeostasis Via Leptin Receptor Signaling Pathway
    1630 Diabetes Volume 65, June 2016 Yang Sun,1 Yili Yang,2 Zhen Qin,1 Jinya Cai,3 Xiuming Guo,1 Yun Tang,3 Jingjing Wan,1 Ding-Feng Su,1 and Xia Liu1 The Acute-Phase Protein Orosomucoid Regulates Food Intake and Energy Homeostasis via Leptin Receptor Signaling Pathway Diabetes 2016;65:1630–1641 | DOI: 10.2337/db15-1193 The acute-phase protein orosomucoid (ORM) exhibits a intake and energy expenditure. Energy homeostasis in the variety of activities in vitro and in vivo, notably modulation body is maintained by the integrated actions of multiple of immunity and transportation of drugs. We found in this factors (1,2), including adipose hormones (such as leptin study that mice lacking ORM1 displayed aberrant energy and adiponectin), gastrointestinal hormones (such as in- homeostasis characterized by increased body weight and sulin, ghrelin, and cholecystokinin), and nutrient-related fat mass. Further investigation found that ORM, predom- signals (such as free fatty acids). In addition to acting on fi inantly ORM1, is signi cantly elevated in sera, liver, and peripheral tissues, these actions can also influence central – adipose tissues from the mice with high-fat diet (HFD) circuits in the hypothalamus, brainstem, and limbic system db/db induced obesity and mice that develop obesity to modulate food intake and energy expenditure (1,3). spontaneously due to mutation in the leptin receptor Notably, the adipose tissue–produced leptin is a major (LepR). Intravenous or intraperitoneal administration of regulator of fat, and the level of leptin in circulation is exogenous ORM decreased food intake in C57BL/6, HFD, proportional to body fat (4) and is a reflection of long- and leptin-deficient ob/ob mice, which was absent in db/db OBESITY STUDIES fi term nutrition status as well as acute energy balance.
    [Show full text]
  • Human Lectins, Their Carbohydrate Affinities and Where to Find Them
    biomolecules Review Human Lectins, Their Carbohydrate Affinities and Where to Review HumanFind Them Lectins, Their Carbohydrate Affinities and Where to FindCláudia ThemD. Raposo 1,*, André B. Canelas 2 and M. Teresa Barros 1 1, 2 1 Cláudia D. Raposo * , Andr1 é LAQVB. Canelas‐Requimte,and Department M. Teresa of Chemistry, Barros NOVA School of Science and Technology, Universidade NOVA de Lisboa, 2829‐516 Caparica, Portugal; [email protected] 12 GlanbiaLAQV-Requimte,‐AgriChemWhey, Department Lisheen of Chemistry, Mine, Killoran, NOVA Moyne, School E41 of ScienceR622 Co. and Tipperary, Technology, Ireland; canelas‐ [email protected] NOVA de Lisboa, 2829-516 Caparica, Portugal; [email protected] 2* Correspondence:Glanbia-AgriChemWhey, [email protected]; Lisheen Mine, Tel.: Killoran, +351‐212948550 Moyne, E41 R622 Tipperary, Ireland; [email protected] * Correspondence: [email protected]; Tel.: +351-212948550 Abstract: Lectins are a class of proteins responsible for several biological roles such as cell‐cell in‐ Abstract:teractions,Lectins signaling are pathways, a class of and proteins several responsible innate immune for several responses biological against roles pathogens. such as Since cell-cell lec‐ interactions,tins are able signalingto bind to pathways, carbohydrates, and several they can innate be a immuneviable target responses for targeted against drug pathogens. delivery Since sys‐ lectinstems. In are fact, able several to bind lectins to carbohydrates, were approved they by canFood be and a viable Drug targetAdministration for targeted for drugthat purpose. delivery systems.Information In fact, about several specific lectins carbohydrate were approved recognition by Food by andlectin Drug receptors Administration was gathered for that herein, purpose. plus Informationthe specific organs about specific where those carbohydrate lectins can recognition be found by within lectin the receptors human was body.
    [Show full text]
  • Protein Analysis Reveals Differential Accumulation of Late
    The following article appeared in BMC Plant Biology, 19: 59 (2019); and may be found at: https://doi.org/10.1186/s12870-019-1656-7 This is an open access article distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license https://creativecommons.org/licenses/by/4.0/ Bojórquez-Velázquez et al. BMC Plant Biology (2019) 19:59 https://doi.org/10.1186/s12870-019-1656-7 RESEARCH ARTICLE Open Access Protein analysis reveals differential accumulation of late embryogenesis abundant and storage proteins in seeds of wild and cultivated amaranth species Esaú Bojórquez-Velázquez1, Alberto Barrera-Pacheco1, Eduardo Espitia-Rangel2, Alfredo Herrera-Estrella3 and Ana Paulina Barba de la Rosa1* Abstract Background: Amaranth is a plant naturally resistant to various types of stresses that produces seeds of excellent nutritional quality, so amaranth is a promising system for food production. Amaranth wild relatives have survived climate changes and grow under harsh conditions, however no studies about morphological and molecular characteristics of their seeds are known. Therefore, we carried out a detailed morphological and molecular characterization of wild species A. powellii and A. hybridus, and compared them with the cultivated amaranth species A. hypochondriacus (waxy and non-waxy seeds) and A. cruentus. Results: Seed proteins were fractionated according to their polarity properties and were analysed in one- dimensional gel electrophoresis (1-DE) followed by nano-liquid chromatography coupled to tandem mass spectrometry (nLC-MS/MS). A total of 34 differentially accumulated protein bands were detected and 105 proteins were successfully identified. Late embryogenesis abundant proteins were detected as species-specific.
    [Show full text]
  • Laboratory Testing for Alpha-1 Antitrypsin Deficiency (AATD)
    NATIONAL LABORATORY HANDBOOK Laboratory Testing for Alpha-1 Antitrypsin Deficiency (AATD) Document reference CSP033/2019 Document developed by National Clinical Programme number for Pathology Revision number Version 1. Document approved by National Clinical Programme for Pathology. Clinical Advisory Group for Pathology. National Clinical Advisor and Group Lead. Approval date 09/2019 Responsibility for Acute Hospital Division implementation Next Revision date 09/2022 Responsibility for review National Clinical Programme and audit for Pathology Table of Contents Key Recommendations for Clinical Users .......................................................................... 3 Key Recommendations for Laboratories ............................................................................ 3 Background & Epidemiology .............................................................................................. 4 Who to Test ....................................................................................................................... 4 Specimen and Ordering Information .................................................................................. 6 How to Test ....................................................................................................................... 6 Interpretation of tests ......................................................................................................... 7 Quality ..............................................................................................................................
    [Show full text]